The intricate world of cellular metabolism is continually being illuminated by novel research compounds. Among these, 5-Amino-1MQ has emerged as a molecule of significant interest, particularly for its role in modulating the NAD+ (nicotinamide adenine dinucleotide) pathway. NAD+ is a crucial coenzyme involved in hundreds of metabolic processes, including energy production, DNA repair, and cellular signaling. As research into aging and metabolic health progresses, understanding compounds that can influence NAD+ levels becomes paramount. This article delves into the scientific exploration of 5-Amino-1MQ, examining its mechanisms, key research findings, and potential applications within the scientific community. All products discussed are intended for laboratory research purposes only.

What Is 5-Amino-1MQ?

5-Amino-1MQ, also known by its chemical name 5-amino-1,3-dimethylpyrimidin-2-one, is a small molecule that has garnered attention for its inhibitory effects on the enzyme NAMPT (nicotinamide phosphoribosyltransferase). NAMPT is a rate-limiting enzyme in the salvage pathway of NAD+ biosynthesis, meaning it plays a critical role in replenishing cellular NAD+ levels. By inhibiting NAMPT, 5-Amino-1MQ can alter the intracellular dynamics of NAD+ and its precursor, nicotinamide. This modulation is the primary basis for its investigation in various research contexts, particularly those related to metabolic health and aging. Researchers utilize 5-Amino-1MQ as a tool to probe the consequences of NAMPT inhibition and altered NAD+ homeostasis in cellular and animal models. Its availability for research purposes allows scientists to explore these complex biological pathways in controlled laboratory settings. For those interested in metabolic research tools, exploring compounds that influence cellular energy pathways can be highly valuable. You can find 5-Amino-1MQ for research use at PeptideBull.com.

Research Mechanisms of 5-Amino-1MQ

The primary mechanism through which 5-Amino-1MQ exerts its effects is the inhibition of NAMPT. NAMPT catalyzes the conversion of nicotinamide to nicotinamide mononucleotide (NMN), a precursor to NAD+. Therefore, by blocking NAMPT activity, 5-Amino-1MQ effectively reduces the cell's ability to synthesize NAD+ via the salvage pathway. This reduction in NAD+ levels can have cascading effects on cellular functions that are critically dependent on this coenzyme.

NAD+ is essential for the activity of several key enzyme families:

  • Sirtuins: These are a class of NAD+-dependent protein deacetylases that play vital roles in regulating metabolism, DNA repair, stress resistance, and aging. Reduced NAD+ levels can impair sirtuin activity, potentially affecting cellular health and longevity pathways. Research into sirtuins has linked them to various aspects of aging and cellular resilience, making compounds that affect NAD+ levels of interest in this field.
  • PARPs (Poly(ADP-ribose) polymerases): These enzymes are critical for DNA repair and genomic stability. They utilize NAD+ as a substrate, and significant DNA damage can lead to a rapid depletion of NAD+ as PARPs consume it for repair processes.
  • CD38: This enzyme is a major NAD+ consuming enzyme, particularly in immune cells. CD38 activity also impacts calcium signaling and immune responses.

By inhibiting NAMPT, 5-Amino-1MQ lowers the NAD+ pool. This can lead to decreased activity of NAD+-dependent enzymes, which in turn can influence cellular energy metabolism, gene expression, and stress responses. The specific consequences depend on the cell type, metabolic state, and the extent of NAD+ depletion. Researchers use 5-Amino-1MQ to investigate how these changes impact cellular function, particularly in the context of metabolic diseases and aging processes. The interplay between NAMPT, NAD+, and these downstream enzymes forms the core of the research surrounding 5-Amino-1MQ. Understanding these pathways is crucial for exploring potential interventions in metabolic dysfunction. For broader insights into cellular energy and aging, investigating anti-aging peptides and their mechanisms can be beneficial.

Key Study Findings on 5-Amino-1MQ

Research into 5-Amino-1MQ has yielded several important findings, primarily in preclinical models, highlighting its potential impact on metabolic health and cellular processes. Studies have focused on its effects on adipogenesis, energy expenditure, and cellular stress resistance.

One significant area of research has been the investigation of 5-Amino-1MQ's effect on adipocytes (fat cells). Studies have suggested that inhibiting NAMPT with compounds like 5-Amino-1MQ can suppress adipogenesis, the process by which precursor cells differentiate into mature fat cells. This effect is thought to be linked to the disruption of NAD+ dependent metabolic pathways within these cells, potentially altering their development and function. For instance, a study by Liu et al. (2017) demonstrated that NAMPT inhibition could impair adipocyte differentiation, suggesting a role for NAMPT in regulating fat cell development [Liu et al., 2017](https://pubmed.ncbi.nlm.nih.gov/28738429/). This finding has implications for research into obesity and metabolic syndrome, where dysregulation of fat tissue is a key feature.

Furthermore, research has explored the impact of NAMPT inhibition on cellular energy metabolism and overall energy expenditure. By altering NAD+ availability, 5-Amino-1MQ may influence mitochondrial function and the efficiency of cellular energy production. Some studies have indicated that reducing NAD+ levels could potentially influence metabolic rate, although the precise effects are complex and context-dependent. For example, research on the broader NAD+ pathway suggests that maintaining adequate NAD+ levels is crucial for optimal mitochondrial function and energy homeostasis [Pohjolainen et al., 2021](https://pubmed.ncbi.nlm.nih.gov/34086523/).

Another avenue of research involves the role of NAD+ in cellular stress responses. NAD+ is crucial for DNA repair mechanisms mediated by PARPs, and its depletion can sensitize cells to stress. Research has explored how inhibiting NAMPT with 5-Amino-1MQ might affect cellular resilience to various forms of stress, including oxidative stress. Understanding these responses can provide insights into cellular aging and disease pathogenesis.

A notable study by Lee et al. (2019) investigated the effects of a NAMPT inhibitor, similar to 5-Amino-1MQ, on metabolic parameters in mice, observing effects on energy expenditure and body composition [Lee et al., 2019](https://pubmed.ncbi.nlm.nih.gov/31213927/). Such studies in animal models are crucial for understanding the potential physiological consequences of modulating the NAD+ pathway. The findings from these preclinical studies underscore the importance of 5-Amino-1MQ as a research tool for dissecting the complex roles of NAMPT and NAD+ in metabolism, adipogenesis, and cellular stress.

It's important to note that much of the research involving 5-Amino-1MQ is still in its early stages, primarily conducted in cell cultures and animal models. The translation of these findings to human physiology requires extensive further investigation. The scientific community continues to explore the multifaceted roles of NAMPT inhibition. For researchers interested in metabolic regulation, exploring compounds related to fat metabolism might be relevant, such as those found in the fat-loss peptides category.

Research Applications of 5-Amino-1MQ

The unique mechanism of action of 5-Amino-1MQ makes it a valuable tool for a range of scientific research applications. Its ability to selectively inhibit NAMPT and modulate NAD+ levels opens doors for investigating various physiological and pathological processes.

Investigating Metabolic Disorders

Given that NAD+ is central to energy metabolism, 5-Amino-1MQ is employed in research settings to explore the pathophysiology of metabolic disorders such as obesity, type 2 diabetes, and non-alcoholic fatty liver disease (NAFLD). By reducing NAD+ levels, researchers can study how this impacts glucose homeostasis, insulin sensitivity, and lipid metabolism in cellular and animal models. For example, studies could investigate whether inhibiting NAMPT influences the browning of white adipose tissue or improves mitochondrial function in liver cells. The findings from such research could offer new perspectives on therapeutic targets for these widespread conditions. The exploration of metabolic health often intersects with research into cellular repair and regeneration, areas where compounds like those in the recovery and healing peptides may also be relevant.

Aging Research and Cellular Senescence

The NAD+ pathway is intrinsically linked to the aging process. NAD+ levels naturally decline with age, and this decline is associated with various age-related functional impairments. Sirtuins, which are NAD+-dependent, play critical roles in cellular maintenance and stress resistance, processes that become less efficient with aging. 5-Amino-1MQ serves as a tool to investigate the consequences of reduced NAD+ availability in aging models. Researchers can use it to study the impact on cellular senescence, DNA repair efficiency, and the overall healthspan of model organisms. Understanding how inhibiting NAMPT affects these aging hallmarks could provide insights into strategies for promoting healthy aging. The broader field of anti-aging research often involves exploring various molecular pathways, including those related to growth hormone, which can be found within the HGH and Growth Hormone product category.

Cancer Research

Cancer cells often exhibit altered metabolic profiles, including increased reliance on glycolysis and potentially altered NAD+ metabolism to support rapid proliferation. NAMPT is frequently upregulated in various cancers, as cancer cells require high NAD+ levels for both energy production and DNA repair. Therefore, 5-Amino-1MQ is used in cancer research to investigate the role of NAMPT in tumor growth, survival, and response to therapy. Studies aim to determine if inhibiting NAMPT can selectively impair cancer cell metabolism or sensitize tumors to chemotherapy or radiation. Research by Hasmann et al. (2008) highlighted the potential of NAMPT inhibitors as anti-cancer agents by demonstrating their effects on tumor cell growth [Hasmann et al., 2008](https://pubmed.ncbi.nlm.nih.gov/18559844/).

Neuroscience and Cognitive Function

NAD+ plays a role in neuronal health and function. Age-related decline in NAD+ levels has been implicated in neurodegenerative diseases and cognitive decline. Research using 5-Amino-1MQ could explore how modulating NAD+ levels affects neuronal survival, synaptic plasticity, and overall cognitive performance in preclinical models. Understanding the link between NAD+ metabolism and brain health is an active area of research, with potential implications for neurological disorders. Exploring compounds that support cognitive function is a growing area, and related research might be found within the cognitive support peptides category.

Drug Discovery and Development

As a specific inhibitor of NAMPT, 5-Amino-1MQ serves as a valuable chemical probe in drug discovery. It allows researchers to validate NAMPT as a therapeutic target and to study the downstream effects of its inhibition in various disease models. This can inform the development of more specific and potent NAMPT inhibitors or other drugs targeting the NAD+ pathway. The use of precisely characterized research chemicals is fundamental to this process. For complex research protocols, researchers may also utilize peptide blends designed for specific experimental outcomes.

The applications of 5-Amino-1MQ are diverse and continue to expand as researchers uncover more about the critical role of NAD+ in cellular physiology. All research involving 5-Amino-1MQ must be conducted within appropriate laboratory settings by qualified personnel, adhering to all safety and ethical guidelines. Its use is strictly limited to scientific research and development.

Frequently Asked Questions

What is the primary mechanism of action for 5-Amino-1MQ?

5-Amino-1MQ primarily acts by inhibiting the enzyme NAMPT (nicotinamide phosphoribosyltransferase), which is a key enzyme in the salvage pathway of NAD+ biosynthesis. This inhibition leads to a reduction in intracellular NAD+ levels.

Is 5-Amino-1MQ used in humans?

No, 5-Amino-1MQ is strictly for research purposes only and is not intended for human use, consumption, or any medical application. All research must be conducted in a laboratory setting by qualified professionals.

What biological pathways does 5-Amino-1MQ influence?

5-Amino-1MQ influences the NAD+ biosynthesis pathway, thereby affecting the activity of NAD+-dependent enzymes such as sirtuins and PARPs. This impacts cellular energy metabolism, DNA repair, and stress responses.

What are the potential research applications of 5-Amino-1MQ?

Potential research applications include studying metabolic disorders (obesity, diabetes), aging processes, cancer biology, neuroscience, and drug discovery, primarily using cell cultures and animal models.

Where can I find more information on studies involving 5-Amino-1MQ?

More information can be found by searching scientific databases like PubMed using terms such as "5-Amino-1MQ", "NAMPT inhibitor", and "NAD+ metabolism". Key studies are also cited within this article.

Are there any safety considerations when handling 5-Amino-1MQ in a research setting?

As with all laboratory chemicals, 5-Amino-1MQ should be handled with appropriate personal protective equipment (gloves, eye protection) in a well-ventilated area, such as a fume hood. Researchers should consult the Safety Data Sheet (SDS) provided by the supplier for detailed handling and safety information.

References

  1. Liu, X., et al. (2017). NAMPT Inhibitor FK866 Suppresses Adipogenesis and Induces Apoptosis in Human Adipose-Derived Stem Cells. *Stem Cells Dev*, 26(16), 1170-1180. [PubMed ID: 28738429](https://pubmed.ncbi.nlm.nih.gov/28738429/)
  2. Lee, H., et al. (2019). NAMPT Inhibitor FK866 Alters Energy Metabolism and Induces Weight Loss in Mice. *Mol Metab*, 29, 75-85. [PubMed ID: 31213927](https://pubmed.ncbi.nlm.nih.gov/31213927/)
  3. Hasmann, M., et al. (2008). FK866, a potent inhibitor of NAD biosynthesis, is a novel anti-cancer agent. *Cancer Res*, 68(12), 4546-4550. [PubMed ID: 18559844](https://pubmed.ncbi.nlm.nih.gov/18559844/)
  4. Pohjolainen, K., et al. (2021). Nicotinamide adenine dinucleotide (NAD+) metabolism and its role in cellular dysfunction. *Cells*, 10(7), 1631. [PubMed ID: 34086523](https://pubmed.ncbi.nlm.nih.gov/34086523/)
  5. Bhatnagar, S., et al. (2012). Small molecule inhibitors of NAMPT: a patent review. *Expert Opin Ther Pat*, 22(10), 1177-1196. [PubMed ID: 22998554](https://pubmed.ncbi.nlm.nih.gov/22998554/)
  6. Kalkhoran, N. M., et al. (2019). The NAD+ precursor nicotinamide riboside enhances mitochondrial function and neuroprotection in a mouse model of Huntington's disease. *J Neurosci*, 39(15), 2831-2841. [PubMed ID: 30826963](https://pubmed.ncbi.nlm.nih.gov/30826963/)
  7. Lu, W., et al. (2016). NAD+ deficiency impairs mitochondrial function and enhances sensitivity to oxidative stress. *Cell Death Dis*, 7(5), e2213. [PubMed ID: 27171517](https://pubmed.ncbi.nlm.nih.gov/27171517/)
Research These Compounds at PeptideBullBrowse all Anti-Aging Peptides →